BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36306132)

  • 1. Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients.
    Rofail D; Griffiths P; Flore G; Hussein M; Sivapalasingam S; Podolanczuk AJ; Rodriguez AM; Mastey V; Gwaltney C
    JAMA Netw Open; 2022 Oct; 5(10):e2239053. PubMed ID: 36306132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
    Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
    J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis.
    Gwaltney C; Ivanescu C; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5105-5125. PubMed ID: 36066745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study.
    Smith A; Greenwood D; Horton M; Osborne T; Goodwin M; Lawrence RR; Winch D; Williams P; Milne R; ; Sivan M
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38724221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies.
    Rofail D; McGale N; Im J; Rams A; Przydzial K; Mastey V; Sivapalasingam S; Podolanczuk AJ
    J Patient Rep Outcomes; 2022 May; 6(1):41. PubMed ID: 35507193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms.
    Lechien JR; Chiesa-Estomba CM; Hans S; Calvo-Henriquez C; Mayo-Yáñez M; Tucciarone M; Vaira LA; Saussez S; Saibene AM
    Acta Otolaryngol; 2021 Jun; 141(6):615-620. PubMed ID: 33733988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough.
    Martin Nguyen A; Bacci E; Dicpinigaitis P; Vernon M
    Ther Adv Respir Dis; 2020; 14():1753466620915155. PubMed ID: 32345170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
    Wright DD; Paty J; Turner-Bowker DM; Bradbury A
    Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study.
    Padilla B; Shields AL; Taylor F; Li X; Mcdonald J; Green T; Boral AL; Lin HM; Akin C; Siebenhaar F; Mar B
    Orphanet J Rare Dis; 2021 Oct; 16(1):434. PubMed ID: 34663404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating.
    Lee JJ; Mahadev A; Kallogjeri D; Peterson AM; Gupta S; Khan AM; Jiramongkolchai P; Schneider JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1132-1139. PubMed ID: 36264557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accidental Bowel Leakage Evaluation: A New Patient-Centered Validated Measure of Accidental Bowel Leakage Symptoms in Women.
    Rogers RG; Sung VW; Lukacz ES; Fairchild P; Arya LA; Barber MD; Markland AD; Siddiqui NY; Bann CM;
    Dis Colon Rectum; 2020 May; 63(5):668-677. PubMed ID: 32032195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures.
    Gater A; Nelsen L; Coon CD; Eremenco S; O'Quinn S; Khan AH; Eckert L; Staunton H; Bonner N; Hall R; Krishnan JA; Stoloff S; Schatz M; Haughney J; Coons SJ;
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1249-1259. PubMed ID: 34896298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy.
    Kawata AK; Revicki DA; Thakkar R; Jiang P; Krause S; Davidson MH; Punzi HA; Padley RJ
    Clin Drug Investig; 2009; 29(4):215-29. PubMed ID: 19301936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2018 Mar; 45(3):397-404. PubMed ID: 29419473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome.
    Sivan M; Preston N; Parkin A; Makower S; Gee J; Ross D; Tarrant R; Davison J; Halpin S; O'Connor RJ; Horton M
    J Med Virol; 2022 Sep; 94(9):4253-4264. PubMed ID: 35603810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Item-level psychometric properties for a new patient-reported psoriasis symptom diary.
    Strober BE; Nyirady J; Mallya UG; Guettner A; Papavassilis C; Gottlieb AB; Elewski BE; Turner-Bowker DM; Shields AL; Gwaltney CJ; Lebwohl M
    Value Health; 2013; 16(6):1014-22. PubMed ID: 24041351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial.
    Gottlieb AB; Warren RB; Augustin M; Garcia L; Cioffi C; Peterson L; Pelligra C; Ciaravino V
    Adv Ther; 2021 Oct; 38(10):5253-5269. PubMed ID: 34471992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.